Positive Airway Pressure Therapy Initiation and Continued Benzodiazepine Use Among Chronic Drug Users
Journal of Sleep Research · 2026-08 · 35 (4)
DOI: 10.1111/jsr.70270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sleep Research, online erschienen am 19.12.2025. Verfasst von Nicholas T Vozoris und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Benzodiazepines, Sleep Initiation and Maintenance Disorders, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ontario Ministry of Health, Ministry of Health, Ontario.
Abstract (Originalsprache)
Treating obstructive sleep apnea (OSA) has been shown to improve concomitant insomnia symptoms, but whether treating OSA translates into reducing sedative medication use is unknown. We evaluated the association between initiating incident positive airway pressure (PAP) therapy and continued benzodiazepine drug receipt among chronic benzodiazepine users. This was a retrospective, population‐based cohort study, analysing Ontario health administrative data from January 1, 2012–March 31, 2020. Persons aged 18 years and older, who were chronic benzodiazepine users, were included. The association of new PAP receipt on benzodiazepine drug discontinuation was evaluated at 3–9 months. Propensity score matching was used to account for potential differences in 40 relevant covariates between new and non‐PAP users to minimise bias. We identified 249,516 chronic benzodiazepine users, of whom 10,688 (4.3%) newly received PAP. In the matched cohort, there was no significant difference in benzodiazepine discontinuation between new PAP and non‐PAP users at 3–9 months follow‐up (8.2% vs. 8.3%, relative risk [RR] 0.98, 95% confidence interval [CI] 0.90–1.07). New PAP receipt was not observed to influence stopping benzodiazepines at 3–9 months after PAP initiation. Therefore, our findings raise some uncertainty about the potential effectiveness of administering PAP therapy to improve concomitant insomnia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada.
- Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- ICES, Toronto, Ontario, Canada.
- Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
- Division of Respirology, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Nicholas T Vozoris, Jin Luo, Peter C Austin, Clodagh M Ryan
Förderung
- Ontario Ministry of Health
- Ministry of Health, Ontario
Zitieren
APA
Vozoris, N. T., Luo, J., Austin, P. C., & Ryan, C. M. (2026). Positive Airway Pressure Therapy Initiation and Continued Benzodiazepine Use Among Chronic Drug Users. Journal of Sleep Research, 35(4). https://doi.org/10.1111/jsr.70270
Vancouver
Vozoris NT, Luo J, Austin PC, Ryan CM. Positive Airway Pressure Therapy Initiation and Continued Benzodiazepine Use Among Chronic Drug Users. Journal of Sleep Research. 2026;35(4). doi:10.1111/jsr.70270
BibTeX
@article{Vozoris2026,
author = {Vozoris, Nicholas T and Luo, Jin and Austin, Peter C and Ryan, Clodagh M},
title = {Positive Airway Pressure Therapy Initiation and Continued Benzodiazepine Use Among Chronic Drug Users},
journal = {Journal of Sleep Research},
year = {2026},
volume = {35},
number = {4},
doi = {10.1111/jsr.70270}
}
EUVIMED